APIDRA
SANOFI-AVENTIS CANADA INC
Quick answers
Is there a shortage of APIDRA in Canada?
No. There is no current shortage of APIDRA 100UNIT reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
APIDRA
SANOFI-AVENTIS CANADA INC
DIN
02279460
Strength
100UNIT
Dosage Form
Solution
Route
Subcutaneous
Active Ingredient
INSULIN GLULISINE (RECOMBINANT DNA ORIGIN)
See all INSULIN GLULISINE (RECOMBINANT DNA ORIGIN) products →Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from SANOFI-AVENTIS CANADA INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
10MCG · DIN 02464276
20MCG · DIN 02464284
DIN 02464349
100UNIT · DIN 02469898
100UNIT · DIN 02469901
100UNIT · DIN 02469871
0.58MG · DIN 02254506
500UNIT · DIN 02422913
2000UNIT · DIN 02422948
3000UNIT · DIN 02422956
1000UNIT · DIN 02422921
4000UNIT · DIN 02448157